Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Monocytic, Acute × etoposide phosphate × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 4 Sarcoma, Ewing 2 Rhabdoid Tumor 2 Medulloblastoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Ganglioneuroblastoma 2 Ependymoma 2 Brain Neoplasms 2 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Pinealoma 1 Osteosarcoma 1 Nervous System Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Histiocytosis, Langerhans-Cell 1 Glioma 1 Enteropathy-Associated T-Cell Lymphoma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Injections 2 Gemtuzumab 2 Decitabine 2 ruxolitinib 1 fludarabine 1 fedratinib 1 Whole-Body Irradiation 1 Thiotepa 1 Tacrolimus 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Methotrexate 1 Daunorubicin 1 Cytarabine 1 Cyclosporins 1 Cyclosporine 1 Cyclophosphamide 1 Busulfan 1 Biopsy 1 Azacitidine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡